Navigation Links
ImmunoVaccine Technologies' DepoVax(TM) Shows Positive Results for Cancer and Infectious Diseases
Date:10/1/2008

HALIFAX, Oct. 1 /PRNewswire/ - ImmunoVaccine Technologies' (IVT) patented depot vaccine formulation, DepoVax(TM) is showing positive pre-clinical results, with single-dose efficacy achieved in therapeutic cancer and several infectious disease vaccine models. The results of this research will be presented October 4th at the Ehrlich II conference in Germany. Collaborators from the University of Miami will also be reporting on the capabilities of IVT's depot formulations for delivery of DNA and SiRNA in vivo.

DepoVax(TM) provides a unique single-dose capability, and is based on a novel approach to the use of liposomes, which encapsulate a target antigen and adjuvant. The vaccine formulation also relies on a hydrophobic oil carrier. The result is a depot effect that significantly enhances vaccine induced cell-mediated and humoral immunity.

The efficacy of a single dose of a DepoVax(TM) formulation was shown using a Human Papilloma Virus (HPV) associated cervical cancer model. In the therapeutic C3 tumor challenge model, DepoVax(TM) eliminated 100% of established cancerous tumors after a single dose. In contrast, tumors remained intact when treated with a placebo vaccine. The effect of the vaccine is linked to the activation of a potent and specific cellular immune response.

"We have developed depot vaccine formulations that can induce a more effective immune response than other vaccination strategies used in the clinic today," said Dr. Marc Mansour, vice president of R&D at IVT. "We look forward to testing our therapeutic cancer formulations in the clinic this coming year."

For the humoral response, a recombinant H5 antigen was used. IVT immunized models once with the DepoVax(TM) vaccine formulation, and once or twice with a control alum-based vaccine for avian influenza. At all time points tested, as early as 18 days and for at least 20 weeks, antibody titers induced by the depot vaccine were 10-15 times higher than a single dose of t
'/>"/>

SOURCE ImmunoVaccine Technologies Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine technology :

1. Wound Management Technologies, Inc. Announces Conference Plans in Boston and Additional Clinical Research on CellerateRx(R)
2. Experts Assert That Varian Technologies Deliver Speed and Clinical Accuracy in Treating Cancer Patients
3. Palatin Technologies Presents PL-3994 Clinical Trial Results at the 12th Annual Scientific Meeting of the Heart Failure Association of America
4. BioSpecifics Technologies Corp. Announces Initiation of Phase IIb Trial for Peyronies Disease
5. Neurobiological Technologies Reaches Patient Enrollment Target For Interim Analysis of Viprinex(TM) Phase 3 Stroke Trials
6. New CyberKnife Technologies Demonstrate Dramatic Reduction in Treatment Times
7. MicroDose Technologies Announces Achievement of Phase I Clinical Milestone Triggering First Milestone Payment Under Collaboration with Merck & Co., Inc.
8. Wound Management Technologies, Inc. Announces Agreement for Evidence Based Study for Diabetic Venous Ulcers
9. Emisphere Technologies Announces the Launch of a Human Clinical Trial For Oral Parathyroid Hormone (PTH)
10. Duke Licenses ALPHADAS(R), Logos Technologies EDC System to Accelerate its Early Phase Clinical Trials
11. Fox Chase Cancer Center and VisEn Medical Announce Program to Advance First Clinical Trials of Novel Fluorescence Molecular Imaging Technologies
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/19/2008)...9 Posit Science Corporation,resea...ty for Neuroscience,Annual Conference in Washingt...ng may benefit Baby Boomers. The computerized bra...es adaptive exercises that target auditory and,la...ve generalized,improvements in cognition by impro...
(Date:11/19/2008)... Isogen, a contract development an... today announced the first,phase launch of its co...,specifically address the process, facility and c...billion highly-niched, low-volume clinical and,ea...t. , Companies can invest over $100 million...
(Date:11/18/2008)...18 Forty-two leading U....ber national forum to consider cutting-edge innova...national economy from outbreaks of dangerous zoono... , Among those innovations: , , , ...en table that detects highly contagious and danger...
(Date:11/13/2008)...search Finds Statins Cut Risk of Heart Attacks, De.../ -- Cardiovascular Disease,is the leading cause o...stem hundreds of millions of dollars and causing u...ing this fatal disease - even among those who,were... that millions of people could cut their risk of a...
Breaking Medicine Technology:New Evidence That Brain-Plasticity Based Training has Broad Impact: Improved Cognition in Boomers, Improved Motor Control in Older Adults 2Isogen Launches Major New Facility to Address Global Biopharma Demand 242 Top U.S. Scientists and Specialists Explore Cutting-Edge Innovations to Defend America From Dangerous Zoonotic Diseases 2Seniors Can Be Heartened by New Study on Statins 2BioMarin Announces Program for ERT for Treatment of MPS IVA Morquio A Syndrome 5837 1BioMarin Announces Program for ERT for Treatment of MPS IVA Morquio A Syndrome 5837 2BioMarin Announces Program for ERT for Treatment of MPS IVA Morquio A Syndrome 5837 3BioMarin Announces Program for ERT for Treatment of MPS IVA Morquio A Syndrome 5837 4Ecological Society of America announces its 93rd Annual Meeting 3540 1Ecological Society of America announces its 93rd Annual Meeting 3540 2Ecological Society of America announces its 93rd Annual Meeting 3540 3A glass apart 21152 1Rush Copley Medical Center Selects Allscripts Electronic Health Record and Practice Management Solution 21148 1Rush Copley Medical Center Selects Allscripts Electronic Health Record and Practice Management Solution 21148 2Rush Copley Medical Center Selects Allscripts Electronic Health Record and Practice Management Solution 21148 3Rush Copley Medical Center Selects Allscripts Electronic Health Record and Practice Management Solution 21148 4
...tor The first human case of West Nile virus (WNV) ...n late June. The CDC has released few details on ...rst documented incidence of the mosquito borne dis...nded RNA flavivirus of about 11 kb. It primarily ... and other vertebrates serving as incidental hosts...
...cerides and cholesterols, vary with genetic predis...of these factors contribute to serum cholesterol a...isk of untoward vascular and cardiac events. Perha... values are so much in the public eye as serum lev...e discussion of plasma lipid test results an oppor...
Other Medicine Technology:West Nile Virus Screening and Diagnostics Technology Emerges In Step with North American Outbreak 2West Nile Virus Screening and Diagnostics Technology Emerges In Step with North American Outbreak 3West Nile Virus Screening and Diagnostics Technology Emerges In Step with North American Outbreak 4Analyzers Offer Point-of-Care Lipid Panels 2Analyzers Offer Point-of-Care Lipid Panels 3
(Date:11/21/2008)...ng may lead to new therapies for preterm labor , ...earchers say they,ve found the switch that activat...dbirth, a finding that may lead to therapies for p...ally binds the protein IP on the surface of these ...tive during pregnancy. , But researchers from ...
(Date:11/21/2008)...al meeting of shareholders to be held on January 8...stCall/ - Med-Emerg International Inc. ("MedEmerg"... of health services, announced today that it has o... Court of Justice concerning its previously announ...nt to which AIM Health Group Inc. ("AIM") will acq...
(Date:11/21/2008)...TON(Nov. 21, 2008)The University of Texas Health S..., Training Excellence in Aging Studies (TEXAS), to...h a prestigious $2 million award from the Donald W...g funds., "This will allow us to teach geriatric ...or medical student to practicing physicians. With ...
(Date:11/21/2008)...AND, Colo., Nov. 21 Hesk...t will present at the New York Society of,Securit...ma Conference on,December 2, 2008 at 1177 Avenue ...resentation is scheduled to begin at 9:35 a.m. Eas...vailable via live webcast and for two weeks,follo...
Breaking Medicine News(10 mins):Health News:Med-Emerg International Inc. obtains interim court order for plan of arrangement with AIM Health Group Inc. 2Health News:Med-Emerg International Inc. obtains interim court order for plan of arrangement with AIM Health Group Inc. 3Health News:UT Houston launches geriatric training with $3.25 million in grant, matching funds 2Health News:UT Houston launches geriatric training with $3.25 million in grant, matching funds 3Health News:UT Houston launches geriatric training with $3.25 million in grant, matching funds 4
...gular heart beats and have a tendency to form bloo...arts. These clots can then travel to the brain, bl...ng the risk of this occurring is to give drugs tha...ots. Two commonly used options are anticoagulants ...
...e chance of successfully quitting can be enhanced ... during their stay, and then have at least one mon... people, going in to hospital provides an opportun...als are now smoke-free, any smoker has to stop tem...
...a huge pink hot air balloon - is set Friday to fly...ness . The balloon - which organisers hope will en...d by seven local branches of the public medical se...al in Lichtenvoorde, a small town near Almelo in t...
...registration in certain parts of India is not sati...ar, 10 million still go unregistered . Two out of ...re do not exist for government planning purposes, ...rnmental organisation (NGO) said. The registratio...
Other Medicine News:Health News:Anticoagulants is Better for Atrial Fibrillation 2Health News:Hospital Provides an Oppurtunity to Quit Smoking 2Health News:Millions of Births Still Go Unreported in India 2
Medical Claims Billing
Managed care is a billing and tracking system.
Visionary OFFICE™ PM offers a Windows interface featuring medical billing, appointment scheduling and patient information.
HCS INTERACTANT is an integrated healthcare information system. Financial applications include general ledger, accounts payable, human resources and comprehensive management reporting. HCS general fi
Medicine Products: